Reported 2 days ago
CVS Health Corporation is positioned as one of the top dividend stocks in the pharmaceutical sector for 2025. Despite a challenging year that impacted its stock, CVS has rebounded with notable growth, reporting $94.6 billion in revenues for Q1 of 2025—up 7% from last year. The company maintains a strong cash flow, enabling uninterrupted dividends to shareholders since 1997, currently at $0.665 per share. While CVS shows promise, analysts suggest that other AI stocks may present better investment opportunities.
Source: YAHOO